Get all your news in one place.

100's of premium titles.
One app.

Get all your news in one place.

100's of premium titles. One news app.

The Latest Breaking News from Pfizer

Pfizer stock surges after activist takes $1 billion stake

The drugmaker has shed nearly $180 billion in market cap after struggling to chart a new course as the COVID-19 pandemic waned.

Fortune

Activist Starboard Takes $1 Billion Stake In Pfizer, Seeks Former Execs' Support: Reports

Starboard has reached out to former Pfizer CEO Ian Read and ex-finance chief Frank D'Amelio, and both have expressed interest in supporting the activist investor's turnaround efforts, reports said.

International Business Times

I thought I was fine with being bald. But the chance of a cure has stirred up all sorts of feelings

It’s almost 30 years since I lost my hair to alopecia. What if Pfizer’s drug Litfulo could bring it back? asks Guardian columnist Emma Beddington

The Guardian - UK

From analysis to the latest developments in health,
read the most diverse news in one place.

RSV can be deadly—especially for older adults. Why aren’t more of them getting the new vaccine?

About 6,000 to 10,000 people 65 and older die from RSV in the U.S. annually, the CDC says.

Fortune

What You Need to Know Ahead of Walgreens Boots Alliance's Earnings Release

With Walgreens Boots Alliance gearing up to release its fourth-quarter earnings later this month, analysts expect a double-digit earnings dip.

Barchart

How to Buy PFE For a 6% Discount, or Achieve a 23% Annual Return

Selling cash secured puts on stocks an investor is happy to take ownership of is a great way to generate some extra income.

Barchart

3 Dividend Stocks Yielding 5% To 11% To Scoop Up Now

These three stocks pay out an attractive yield.

Barchart

Read news from The Economist, FT, and more,
with one subscription

It's time to roll up sleeves for new COVID, flu shots

Fall means it’s time for just about everybody to get up to date on their flu and COVID-19 vaccines

The Independent UK

Free COVID-19 Test Kits To Be Available Again

The new kits were supposed to be available for order on Monday

International Business Times

New Migraine Drugs No Better Than Cheap Painkillers: Big Study

Migraine drugs can represent big money for pharmaceutical firms, as shown when Pfizer acquired Biohaven -- which developed rimegepant -- for more than $10 billion in 2022.

Latin Times

Will the XEC COVID subvariant bring a fall wave of infections? What to know about symptoms and spread

The U.S. is coming down from its biggest COVID summer surge yet as a new subvariant emerges—but new vaccines are here, too.

Fortune

Covid conspiracy theorist convicted of terrorism after Telegram calls for vaccine violence

Patrick Ruane, 55, from Paddington, west London, weaponised social media app Telegram to encourage attacks

Evening Standard

New COVID vaccines may be coming to Australia. Here’s what to know about the JN.1 shots

COVID vaccines have unquestionably made a huge difference during this pandemic. For example, it’s estimated COVID shots have saved more than 1.4 million lives in the World Health Organization’s (WHO) European region alone since their introduction in December 2020.

The Conversation

A mural honoring scientists hung in Pfizer's NYC lobby for 60 years. Now it's up for grabs

A New York City mural honoring ancient and modern figures in medicine could end up in pieces if it can’t find a new patron soon

The Independent UK

Get all your
news in one place.

100's of premium titles.
One news app.

Barchart

You Can Stop Looking, Here's the Perfect Stock for the Current Market

While technology stocks continue to struggle, stocks in the lucrative over-the-counter healthcare products sector are thriving. One prominent such name is Haleon. Its stock has jumped more than 22% over the past three months, as sales and profits in its nine large-scale multinational, high-margin 'power brands' continue to hold leading…

Barchart

Is Pfizer Stock Underperforming the Dow?

Although Pfizer underperformed the Dow Jones this year, analysts are moderately bullish on the stock’s prospects.

The Conversation

COVID-19, flu and RSV shots − an epidemiologist explains why all three matter this fall

The Food and Drug Administration approved and granted emergency use authorization on Aug. 22, 2024, for the newest, updated version of the COVID-19 vaccine. The Centers for Disease Control and Prevention quickly endorsed the new shot to protect against severe illness.

Fortune

New COVID vaccines are here. What to know about 2024–25 shots as summer surge continues

Citing skyrocketing COVID spread, the FDA announced in late August that it had approved Pfizer’s Comirnaty and Moderna’s Spikevax vaccines early.

Get all your
news in one place.

100's of premium titles.
One news app.

The Times of India

When is Canada launching new Covid vaccines targeting KP.2 variant? All you want to know

Close on the heels of US approving vaccines to fight KP.2 variant of Omicron, Health Canada has said they are reviewing updated vaccines that target the strain currently in circulation. The health regulator has said the review process will be completed by early autumn, post which the vaccines will be…

The Independent UK

A new Covid vaccine is available. Here’s why some people might not want it right away

Updated Covid vaccines were approved by the FDA earlier this month

Top News

FDA Approves Updated Covid-19 Vaccines From Moderna And Pfizer

FDA approves updated Covid-19 vaccines from Moderna and Pfizer/BioNTech to enhance protection against current variants and combat rising cases.

The Times of India

New Covid vaccines targeting KP.2 variant approved; 5 things to know

As the summer wave, dominated by FlirT variants, takes over the United States, The Food and Drug Administration has approved updated Covid-19 vaccines that specifically target recent variant of the disease - KP.2.

Medical Daily

Updated COVID mRNA Vaccines Get FDA Approval: Here's What To Know

The updated COVID shots from Pfizer-BioNTech and Moderna target the current KP.2 strain of SARS-CoV-2, a descendant of the highly contagious Omicron subvariant JN.1.

Barchart

3 High-Yield S&P 500 Stocks to Buy and Hold

Three high-yield S&P 500 stocks, Devon Energy, Verizon Communications, and Pfizer Inc., are poised to provide a balanced mix of income and growth, making them attractive options for long-term investors.

Salon

New COVID vaccines approved early

New shots from Pfizer and Moderna will be available within days. Here's how to get yours

1 … 13 14 15 16

People

From analysis to the latest developments in health,
read the most diverse news in one place.

Organisations

World Health Organization

Food and Drug Administration

336 stories

TGA

320 stories

Centers for Disease Control and Prevention

314 stories

Pfizer Inc

313 stories

Read news from The Economist, FT, and more,
with one subscription

Topics

Places

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.